Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,351.25 Average Target Price from Analysts

Mettler-Toledo International Inc. (NYSE:MTD) has been given an average recommendation of “Hold” by the nine research firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and one has assigned a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $1,351.25.

MTD has been the subject of several analyst reports. Wells Fargo & Company cut their target price on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus cut their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wolfe Research started coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. Finally, Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th.

Mettler-Toledo International Trading Up 0.3 %

Shares of NYSE MTD opened at $1,234.39 on Friday. The firm has a market capitalization of $26.05 billion, a price-to-earnings ratio of 33.28, a PEG ratio of 4.21 and a beta of 1.13. Mettler-Toledo International has a one year low of $1,115.64 and a one year high of $1,546.93. The business has a fifty day simple moving average of $1,283.82 and a 200 day simple moving average of $1,370.13.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The business had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. On average, research analysts anticipate that Mettler-Toledo International will post 40.42 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now directly owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now owns 240 shares of the company’s stock, valued at approximately $314,820. This represents a 24.05 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Institutional Investors Weigh In On Mettler-Toledo International

A number of institutional investors have recently made changes to their positions in MTD. UMB Bank n.a. raised its holdings in Mettler-Toledo International by 6.6% in the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock worth $158,000 after purchasing an additional 7 shares during the period. DT Investment Partners LLC lifted its holdings in Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 8 shares in the last quarter. Suncoast Equity Management grew its position in shares of Mettler-Toledo International by 2.0% in the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock valued at $690,000 after purchasing an additional 9 shares during the period. Bleakley Financial Group LLC increased its position in shares of Mettler-Toledo International by 1.2% during the third quarter. Bleakley Financial Group LLC now owns 757 shares of the medical instruments supplier’s stock worth $1,135,000 after acquiring an additional 9 shares in the last quarter. Finally, Huntington National Bank increased its holdings in Mettler-Toledo International by 20.0% during the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 9 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.